Area of research
Surgery · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Percutaneous coronary intervention and Myocardial infarction, with related work in Cardiology, Lesion, Coronary artery disease. Notable publications include 'Cyclosporine before PCI in Patients with Acute Myocardial Infarction', 'Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial', and 'Contemporary Approach to Coronary Bifurcation Lesion Treatment'.
Risk Burden of Cancer in Patients Treated With Abbreviated Dual Antiplatelet Therapy After PCI: Analysis of Multicenter Controlled High-Bleeding Risk Trials
First randomised controlled trial comparing the sirolimus-eluting bioadaptor with the zotarolimus-eluting drug-eluting stent in patients with de novo coronary artery lesions: 12-month clinical and imaging data from the multi-centre, international, BIODAPTOR-RCT
Assessing the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After Coronary Stent Implantation
Global Approach to High Bleeding Risk Patients With Polymer-Free Drug-Coated Coronary Stents
Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing <scp>TAVI</scp> for severe aortic stenosis: Insights from the <scp>WIN‐TAVI</scp> registry
TCT-835 Validation of PARIS Risk Scores in Patients Treated With Everolimus-Eluting Stents for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial
Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial
Contemporary Approach to Coronary Bifurcation Lesion Treatment
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Impact of pre‐ and post‐procedural anemia on the incidence of acute kidney injury and 1‐year mortality in patients undergoing transcatheter aortic valve implantation (from the <scp>F</scp>rench <scp>A</scp>ortic <scp>N</scp>ational <scp>C</scp>ore<scp>V</scp>alve and <scp>E</scp>dwards 2 [<scp>FRANCE</scp> 2] <scp>R</scp>egistry)
Rationale and design of the Cyclosporine to ImpRove Clinical oUtcome in ST-elevation myocardial infarction patients (the CIRCUS trial)